Aligos Therapeutics, Inc.
ALGS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001799448
No open-market purchases or sales by Aligos Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $13.2M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Q3 2021 vs. Q2 2021
How the institutions holding Aligos Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 58 | 68 | +10 |
| Shares | 27.0M | 31.2M | +4.19M (+15.5%) |
| Value | $550.5M | $483.9M | −$66.6M (−12.1%) |
New holders (16)
Institutions that held Aligos Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sphera Funds Management Ltd. | 249,197 | $3.87M | 0.38% |
| Norges Bank | 102,400 | $1.59M | 0.00% |
| Point72 Asset Management, L.P. | 97,300 | $1.51M | 0.01% |
| Two Sigma Investments, LP | 89,863 | $1.39M | 0.00% |
| Millennium Management LLC | 69,943 | $1.08M | 0.00% |
| Renaissance Technologies LLC | 53,200 | $825.0K | 0.00% |
| Altium Capital Management LP | 33,492 | $519.0K | 0.14% |
| Two Sigma Advisers, LP | 16,500 | $256.0K | 0.00% |
| Algert Global LLC | 16,146 | $250.0K | 0.03% |
| Jump Financial, LLC | 16,100 | $250.0K | 0.02% |
| Credit Suisse AG | 13,624 | $211.0K | 0.00% |
| SG Americas Securities, LLC | 8,383 | $130.0K | 0.00% |
| Macquarie Group Ltd | 5,786 | $90.0K | 0.00% |
| Advisor Group Holdings, Inc. | 4,500 | $70.0K | 0.00% |
| O'Shaughnessy Asset Management, LLC | 3,261 | $51.0K | 0.00% |
| Point72 Hong Kong Ltd | 1,357 | $21.0K | 0.00% |
Sold out (6)
Institutions that held Aligos Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| VR Adviser, LLC | 408,377 | $8.32M |
| Acuta Capital Partners, LLC | 214,254 | $4.37M |
| Jacobs Levy Equity Management, Inc | 24,889 | $507.0K |
| Citadel Advisors LLC | 16,355 | $334.0K |
| Qube Research & Technologies Ltd | 15,237 | $311.0K |
| Hamilton Lane Advisors LLC | 12,127 | $247.0K |